FDA.reportPublic FDA data

Vabrinty 22.5 MG in 0.375 ML (3 month) Prefilled Syringe

RxCUI
2720345
RxNorm name
Vabrinty 22.5 MG in 0.375 ML (3 month) Prefilled Syringe
Display name
Vabrinty 22.5 MG in 0.375 ML (3 month) Prefilled Syringe
Full name
Vabrinty 22.5 MG in 0.375 ML (3 month) Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VabrintyLEUPROLIDE ACETATEURONOVA PHARMACEUTICALS, INC.008776cc-83f1-4f8c-819b-6471425da15f2026-04-30Warnings, Adverse reactionsExact identifier
rxcui: 2720345

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
008776cc-83f1-4f8c-819b-6471425da15fVabrinty 22.5 MG in 0.375 ML (3 month) Prefilled SyringePSN9These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220250601
008776cc-83f1-4f8c-819b-6471425da15fVabrinty 22.5 MG per 0.375 ML Prefilled SyringeSY9These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220250601
008776cc-83f1-4f8c-819b-6471425da15f0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Vabrinty]SBD9These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220250601